作者:
Alessandra,Fabi [1]
;
Irene,Terrenato [2]
;
Antonello,Vidiri [3]
;
Veronica,Villani [4]
;
Antonio,Tanzilli [5]
;
Mario,Airoldi [5]
;
Fulvia,Pedani [6]
;
Valentina,Magri [6]
;
Michela,Palleschi [7]
;
Michela,Donadio [8]
;
Giovanni,Catania [9]
;
Cecilia,Nisticò [1]
;
Carmine,Carapella [1]
;
Roberta,Rudà [10]
;
Andrea,Pace [11]
;
Marta,Maschio [5]
;
Stefano,Telera [5]
;
Francesco,Cognetti [10]
;
AINO (Associazione Italiana Neuro-Oncologia) [1]
作者单位:
Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53 - 00144, Rome, Italy.
[1]
Phase I Clinical Studies & Precision Medicine, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53 - 00144, Rome, Italy.
[2]
Clinical Trial Center - Biostatistics & Bioinformatics, IRCCS Regina Elena National Cancer Institute, 53 - 00144, Rome, Italy.
[3]
Radiology & Diagnostic Imaging, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53 - 00144, Rome, Italy.
[4]
Neuroncology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53 - 00144, Rome, Italy.
[5]
Medical Oncology, Health & Science City, Corso Bramante 88, 10126, Turin, Italy.
[6]
Medical Oncology, La Sapienza University, Piazzale Aldo Moro 5, 00185, Rome, Italy.
[7]
Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, 47014, Italy.
[8]
Medical Oncology, Breast Unit, Health & Science City, Corso Bramante 88, 10126,Turin, Italy.
[9]
Neurosurgery Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53 - 00144, Rome, Italy.
[10]
Department of Neuro-Oncology, City of Health & Science, Corso Bramante 88, 10126, Turin, Italy.
[11]
DOI
10.2217/fon-2021-0300
PMID
34044585
发布时间
2022-01-17